Mr. Steve Campbell reports

BURCON INCREASES NON-BROKERED PRIVATE PLACEMENT OF CONVERTIBLE DEBENTURES TO $6.9 MILLION

In response to strong demand, Burcon NutraScience Corp. has increased the size of its previously announced non-brokered private placement of convertible debentures to an aggregate principal amount of up to $6.9-million. For additional details, please refer to the company's news release dated Jan. 2, 2026.

"We are encouraged by the strong investor interest in a challenging market," said Kip Underwood, Burcon's chief executive officer. "With continued support from insiders and major shareholders, we are accelerating our production and sales timeline and reaffirm our revenue target of more than $10-million for calendar 2026."

Insiders of the company and Burcon's manufacturing partner owners are committed to participating at a minimum of $5.0-million in principal amount. The private placement has been conditionally approved by the Toronto Stock Exchange (TSX) subject to Burcon complying with the terms of such conditional approval, including receipt of disinterested shareholder approval.

About Burcon NutraScience Corp.

Burcon is a global technology leader in high-performance plant-based proteins for the food and beverage industry. The company's commercial ingredients offer superior taste, texture and functionality -- ideal for formulators seeking next-generation protein solutions. Backed by over two decades of innovation, Burcon holds an extensive patent portfolio covering novel proteins derived from pea, canola, soy, hemp, sunflower and other plant sources. As a key player in the rapidly growing plant-based market, Burcon is committed to sustainability and to creating best-in-class protein solutions that are better for people and the planet.

We seek Safe Harbor.